Endoscopic Surveillance of Chronic Inflammatory Bowel Disease

Inflammatory bowel disease, ulcerative rectocolitis and Crohn’s disease are a major public health problem. The incidence of ulcerative rectocolitis (UC), which has remained stable since the early eighties, is around 10 per 100 000 inhabitants [1]. Crohn’s disease (CD) appears to be on the increase, with a global incidence of 5.6 / 100 000 [1]. These diseases are associated with a risk of digestive cancer, which justifies regular endoscopic surveillance. Unfortunately, there is no properly-defined code for such surveillance, which is performed on an empirical basis.

References<!?show $^DOIziffer>

• 1 Shivananda S, Lennard-Jones J, Logan R. et al . Incidence of inflammatory bowel disease across Europe: is there a difference between north and South? Results of the European collaborative study on inflammatory bowel disease.  Gut. 1996;  39 690-697
• 2 Eaden J A, Mayberry J F. Colorectal cancer complicating ulcerative colitis: a review.  Am J Gastroenterol. 2000;  95 2710-2719
• 3 Eaden J A, Abrams K, Mayberry J F. The true risk of colorectal cancer in ulcerative colitis: A meta-analysis.  Gut. 1999;  44 (suppl l) T163(abstract)
• 4 Provenzale D, Kowdley K V, Arora S. et al . Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.  Gastroenterology. 1995;  109 1188-1196
• 5 Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease.  Am J Gastroenterol. 1996;  91 44-48
• 6 Bernstein C N, Blanchard J F, Kliewer E, Wadja A. Cancer risk in patients with inflammatory bowel disease.  Cancer. 2001;  91 854-862
• 7 Friedman S, Rubin P H, Bodian C, Harpaz N, Present D. Screening and surveillance colonoscopy in chronic Crohn’s colitis.  Gastroenterology. 2001;  120 820-826
• 8 Farrell R J, Ang Y, Kileen P, O’Briain D SO, Kelleher D, Keeling P W. et al . Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.  Gut. 2000;  47 514-519
• 9 Connell W R, Talbot I C, Harpaz N. et al . Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.  Gut. 1994;  35 1419-1423
• 10 Odze R D. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological and molecular review.  Am J Gastroenterol. 1999;  94 1746-1750
• 11 Kiesslich R, Fritsch J, Holtmann M, Koehler H H, Stolte M, Kanzler S. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888
• 12 Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis.  Am J Gastroenterol. 2003;  98 1827-1833
• 13 Connell W R, Lennard-Jones J E, Williams C B. et al . Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.  Gastroenterology. 1994;  107 934-944
• 14 Choi P M, Nugent F W, Schoetz D J. et al . Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.  Gastroenterology. 1993;  105 418-424
• 15 Engelsgjerd M, Farraye F A, Odze R D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.  Gastroenterology. 1999;  117 1288-1294
• 16 Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis.  Gut. 2000;  46 500-506
• 17 Provenzale D, Wong J, Onken J E, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulceratuve colitis. L.  Am J Gastroenterol. 1998;  93 872-880